Close Menu

NEW YORK – Ginkgo Bioworks and Berkeley Lights said today that they have inked a $150 million deal to incorporate Berkeley Lights' Beacon optofluidic platform into Ginkgo's automated genetic engineering foundries.

Under the multi-year, non-exclusive deal, Boston-based Ginkgo will acquire Beacon platforms from Emeryville, California-based Berkeley Lights and fund the development of workflows to use them in a variety of microbial and mammalian organisms, a Ginkgo spokesperson said in an email.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Department of Justice has proposed a rule change to enable DNA to be collected from migrants, the Associated Press reports.

Bernard Fisher, a surgeon who changed how breast cancer is treated, has died at 101, the New York Times reports.

Washington Post columnist writes that she is skeptical about DNA-based diets.

In PNAS this week: recurrent inactivation of DEPDC5 in gastrointestinal stromal tumors, taxonomic reliability of GenBank sequences, and more.